Your browser doesn't support javascript.
loading
Role of cytotoxic T cells and PD-1 immune checkpoint pathway in papillary thyroid carcinoma.
Banerjee, Sohini; Nahar, Uma; Dahiya, Divya; Mukherjee, Soham; Dey, Pranab; Gupta, Rijuneeta; Radotra, Bishan; Sachdeva, Naresh; Sood, Ashwani; Bhadada, Sanjay Kumar; Bhansali, Anil.
Afiliación
  • Banerjee S; Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Nahar U; Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Dahiya D; Department of General Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Mukherjee S; Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Dey P; Department of Cytology and Gynaecological Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Gupta R; Department of Otolaryngology (ENT), Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Radotra B; Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Sachdeva N; Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Sood A; Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Bhadada SK; Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Bhansali A; Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Front Endocrinol (Lausanne) ; 13: 931647, 2022.
Article en En | MEDLINE | ID: mdl-36518249
ABSTRACT

Background:

Lymphocytic thyroiditis (LT) is frequently seen in the tumor microenvironment (TME) of papillary thyroid carcinomas (PTCs). However, the characteristic of these tumor-infiltrating lymphocytes (TILs) is not well understood.

Objective:

We aim to define the TME of PTC cases by characterizing the TILs.

Design:

This is a cross-sectional observational study. Patients We enrolled 29 PTC (23 having concurrent LT), 14 LT, and 13 hyperplastic nodules with LT (HN) patients from January 2016 to December 2020. Measurements Immunohistochemical (IHC) expression of CD8, FoxP3, PD-1, and PD-L1 was studied in PTC with LT and compared with HN. PD-1 and PD-L1 expression was correlated at the mRNA level by quantitative real-time PCR. Immunophenotyping of TILs was done in FNAC samples of PTC and LT by flow cytometry.

Results:

IHC revealed the presence of CD8+ cytotoxic T lymphocytes (CTLs) and FoxP3+ T regulatory cells (Tregs) in 83% and 52% of PTC with LT cases, respectively. Flow cytometric analysis of the PTC samples revealed a significant abundance of CTL compared with Treg and a higher CTL with lower Treg counts compared with LT. On IHC, PD-1 positivity was noted in 56.5% of PTC with LT cases, while intermediate PD-L1 positivity was found in 70% of the cases. There was a significant upregulation of PD-1 mRNA in PTC with LT. A significant correlation was noted with PD-L1 expression with lymph node metastasis and presence of Treg cells.

Conclusions:

Increased expression of PD-1 and PD-L1 in the TME of PTC may provide a potential molecular mechanism for tumor survival despite the predominance of CTLs, possibly through their inactivation or exhaustion.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiroiditis Autoinmune / Neoplasias de la Tiroides / Enfermedad de Hashimoto Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiroiditis Autoinmune / Neoplasias de la Tiroides / Enfermedad de Hashimoto Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2022 Tipo del documento: Article País de afiliación: India